
When Does a Gold Standard Stop Being Golden?
Direct Laryngoscopy is still a core skill. This is not a “DL is bad” argument. This is a default-setting argument.
The Evidence for a New Default
If your goal is safer intubation in critically ill patients, first-pass success has to drive the decision. In the DEVICE trial, first-pass success was 85.1% with video laryngoscopy vs 70.8% with direct laryngoscopy.[1] That is a 14.3-point absolute difference. In airway management, that is not small.
The usual pushback is “we can predict difficult airways.” We cannot do that reliably enough. In INTUBE, complications occurred at meaningful rates in critically ill intubations across diverse settings, and risk escalated with repeated attempts.[2] So the practical reality is simple: if prediction is imperfect, your default needs to be robust when attempt one matters most.
DEVICE Trial, First-Pass Success Rate
85.1%
Video Laryngoscopy
(VL)
70.8%
Direct Laryngoscopy
(DL)
Prekker ME, et al. N Engl J Med, 2023 · 14.3-point absolute difference
Why Attempt One Matters Most
With additional attempts, adverse events increase, including hypoxemia, hemodynamic instability, and esophageal intubation risk.[2] That is why first-pass success is a patient safety metric, not just a performance stat.
“First-pass success is a patient safety metric, not just a performance stat.”
A Better Training Model
Training is another reason this matters. With DL, the trainee sees the view and the attending often does not. Feedback is delayed. With VL, both see the airway in real time. Coaching improves immediately. Adoption data has shown this pattern before: early resistance, then broad support after exposure and routine use.[4][3]
Direct Laryngoscopy Still Has a Role
The DL-skills objection is legitimate. You still need DL for specific scenarios: heavy contamination, equipment failure, and select anatomy. The right answer is not “abandon DL.” The right answer is “default to VL where evidence supports it, and deliberately preserve DL proficiency.” Even recent guidance flags perceived DL skill loss as a major adoption barrier.[3]
A Measurement Caveat
There is also a measurement caveat. “First-pass success” is not defined identically everywhere. When definitions include stricter tube-delivery criteria, reported rates can drop by about five points.[5] That should make us careful with cross-site comparisons, not dismissive of the overall signal.
Bottom Line
Standards should move when evidence moves. Macintosh laryngoscopy was a major advance. It still has a role. But if we are serious about safety in ICU, ED, and resource-constrained environments, we should stop treating legacy default as sacred and start treating first-pass success as the primary endpoint.[1][2]
References
- [1]Prekker ME, et al. Video versus Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults (DEVICE). N Engl J Med. 2023.
- [2]Russotto V, et al. INTUBE: International observational study of tracheal intubation practices and adverse events in critically ill patients. JAMA. 2021.
- [3]Ahmad I, et al. Difficult Airway Society guidance and barriers to VL adoption. Br J Anaesth. 2026.
- [4]Cook TM, Kelly FE. National survey on video laryngoscopy uptake and training. Br J Anaesth. 2017.
- [5]Trent SA, et al. Effect of first-pass-success definitions on reported success rates. Ann Emerg Med. 2023.

About the Author
Andrew Napier, M.D.
Founder/CEO & ER Physician
Purple Heart recipient and emergency physician who built IntuBlade from a battlefield concept to an FDA-registered Class I medical device platform. His clinical experience spans combat medicine, civilian EMS, and academic emergency departments.
Is Your Team Equipped for the First Attempt?
IntuBlade was founded by an ER physician and combat medic to ensure every provider has access to life-saving tools, regardless of budget.
Learn About the National Airway Access InitiativeRelated Intelligence
First-Line Videolaryngoscopy: Commentary on the 2025 DAS Guidelines
By Benjamin T. Fedeles, M.D.
Why QA/QI Matters in Medical Devices: A Physician’s Perspective
By Andrew Napier, MD
Looking for the AJEM peer-reviewed data? Visit the Research Page
